Edit

Dayton Group

Organoid models of neuroendocrine development and cancer

Externally Funded Projects

Unravelling the interplay between genetics and inflammation in the formation of lung neuroendocrine cancer

Funding Body: Asociación Española Contra el Cancer – Grant PID2023-152948NA-I00 funded by MCIN/ AEI /10.13039/501100011033/FEDER/EU.

Start Date: Dec 2024

Timeframe: 3 years

Cancer-GENOXIC, Genetics, hypoxia, and nicotine: Unravelling the tangled web of interactions contributing to lung neuroendocrine cancer

Funding Body: Spanish National Grant – Grant PID2023-152948NA-I00 funded by MCIN/ AEI /10.13039/501100011033/FEDER/EU.

Start Date: Sept 2024

Timeframe: 33 years

Using patient-derived tumor organoids to uncover mechanisms of pulmonary NET progression 

Funding Body: Investigator Award – Neuroendocrine Tumor Research Foundation (NETRF).

Start Date: Feb 2024

Timeframe: 3 years

Using patient-derived tumor organoids to uncover growth factor dependencies and therapeutic vulnerabilities in neuroendocrine malignancies

Funding Body: GETNE (Grupo Español de Tumores Neuroendocrinos y Endocrinos; Spanish Neuroendocrine Tumor Task Force).

Start Date: Feb 2024

Timeframe: 3 years

Edit